Elevation Oncology Inc Stock
Elevation Oncology Inc Stock price
Key metrics
| Market capitalization | $22.86m |
| Enterprise Value | $-39.19m |
| P/E (TTM) P/E ratio | negative |
| P/B ratio (TTM) P/B ratio | 0.38 |
| Revenue (TTM) Revenue | $0.00 |
| EBIT (operating result TTM) EBIT | $-44.70m |
| Cash position | $93.18m |
| EPS (TTM) EPS | $-0.80 |
| P/E forward | negative |
Is Elevation Oncology Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.
Elevation Oncology Inc Stock Analysis
Analyst Opinions
8 Analysts have issued a Elevation Oncology Inc forecast:
Analyst Opinions
8 Analysts have issued a Elevation Oncology Inc forecast:
Financial data from Elevation Oncology Inc
| Dec '24 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | -0.02 -0.02 |
50%
50%
|
|
| EBITDA | -45 -45 |
11%
11%
|
EBIT (Operating Income) EBIT | -45 -45 |
11%
11%
|
| Net Profit | -44 -44 |
3%
3%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Elevation Oncology Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Elevation Oncology Inc Stock News
Company Profile
Elevation Oncology, Inc. operates as a precision oncology company. It focuses on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations. The firm’s program is focused on patients with advanced solid tumors harboring an NRG1 fusion. The company was founded by Shawn M. Leland in 2019 and is headquartered in New York, NY.
| Head office | United States |
| CEO | Joseph Ferra |
| Employees | 34 |
| Founded | 2019 |
| Website | www.elevationoncology.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
